Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 3
2013 4
2014 3
2015 3
2016 3
2017 2
2018 4
2019 2
2020 8
2021 9
2022 8
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

43 results
Results by year
Filters applied: . Clear all
Page 1
Clinical outcomes of breakthrough COVID-19 after booster vaccination in patients with systemic rheumatic diseases.
Fragoulis GE, Karamanakos A, Arida A, Bournia VK, Evangelatos G, Fanouriakis A, Fragiadaki K, Kravvariti E, Laskari K, Panopoulos S, Papazoglou N, Pappa M, Tektonidou MG, Sfikakis PP. Fragoulis GE, et al. Among authors: panopoulos s. RMD Open. 2022 Mar;8(1):e002279. doi: 10.1136/rmdopen-2022-002279. RMD Open. 2022. PMID: 35246472 Free PMC article. No abstract available.
Treatment adherence of patients with systemic rheumatic diseases in COVID-19 pandemic.
Fragoulis GE, Evangelatos G, Arida A, Bournia VK, Fragiadaki K, Karamanakos A, Kravvariti E, Laskari K, Panopoulos S, Pappa M, Tektonidou MG, Sfikakis PP. Fragoulis GE, et al. Among authors: panopoulos s. Ann Rheum Dis. 2021 Apr;80(4):e60. doi: 10.1136/annrheumdis-2020-217935. Epub 2020 May 31. Ann Rheum Dis. 2021. PMID: 32475830 No abstract available.
Better outcomes of COVID-19 in vaccinated compared to unvaccinated patients with systemic rheumatic diseases.
Papagoras C, Fragoulis GE, Zioga N, Simopoulou T, Deftereou K, Kalavri E, Zampeli E, Gerolymatou N, Kataxaki E, Melissaropoulos K, Panopoulos S, Fragiadaki K, Evangelatos G, Bournia VK, Arida A, Karamanakos A, Pappa M, Panagiotopoulos A, Koutsianas C, Mparouta G, Dimitroulas T, Liossis SN, Tektonidou MG, Kravvariti E, Kougkas N, Georgiou P, Voulgari P, Elezoglou A, Bogdanos DP, Vassilopoulos D, Sfikakis PP. Papagoras C, et al. Among authors: panopoulos s. Ann Rheum Dis. 2022 Jul;81(7):1013-1016. doi: 10.1136/annrheumdis-2021-221539. Epub 2021 Nov 10. Ann Rheum Dis. 2022. PMID: 34758975
Oral antiviral treatment in patients with systemic rheumatic disease at risk for development of severe COVID-19: a case series.
Fragoulis GE, Koutsianas C, Fragiadaki K, Mariolis I, Panopoulos S, Tsalapaki C, Pappa M, Dimitroulas T, Tektonidou MG, Vassilopoulos D, Sfikakis PP. Fragoulis GE, et al. Among authors: panopoulos s. Ann Rheum Dis. 2022 Jun 14:annrheumdis-2022-222845. doi: 10.1136/annrheumdis-2022-222845. Online ahead of print. Ann Rheum Dis. 2022. PMID: 35701154 No abstract available.
COVID-19 vaccine safety and nocebo-prone associated hesitancy in patients with systemic rheumatic diseases: a cross-sectional study.
Fragoulis GE, Bournia VK, Mavrea E, Evangelatos G, Fragiadaki K, Karamanakos A, Kravariti E, Laskari K, Panopoulos S, Pappa M, Mitsikostas DD, Tektonidou MG, Vassilopoulos D, Sfikakis PP. Fragoulis GE, et al. Among authors: panopoulos s. Rheumatol Int. 2022 Jan;42(1):31-39. doi: 10.1007/s00296-021-05039-3. Epub 2021 Nov 5. Rheumatol Int. 2022. PMID: 34739573 Free PMC article.
43 results